Netherlands· NL-2a8884fa352f

Ejulir 6 mg/ml oplossing voor injectie in een voorgevulde pen

A liraglutide product containing liraglutide, registered in Netherlands by Viatris Limited. The same ATC class is registered in 16 of our 19 countries.

ATC A10BJ02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about liraglutideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Liraglutide is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BJ02 (liraglutide), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search liraglutide products by name

Liraglutide · ATC A10BJ02

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: LIRAGLUTIDE
Manufacturer: Viatris Limited
Country: Netherlands (NL)
ATC code: A10BJ02
ATC class: Liraglutide
Defined daily dose: 1.5 mg, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
133503

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

309 interactions on record for liraglutide.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check liraglutide against other medicines How interaction checks work

Liraglutide · interactions on record

309 records

3 severe
260 moderate
46 minor

Most severe, free to view

GatifloxacinJ01MA16severe
SucralfateA02BX02moderate
ThiethylperazinA04AB03moderate
TriflupromazinA04AD06moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Liraglutide in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All liraglutide products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Ejulir, Lirabelin
Belgium · Byesilor, Zinnentis
Bulgaria · Зеглуксен
Czechia · Ejulir, Plyzari
Germany · Byesilor, Diavic
Denmark · Ejulir, Liraglutid "biogaran"
Estonia · Liraglutide Zentiva, Siluxir
Spain · Byesilor, Diavic
Finland · Diavic, Metlyra
France · Liendax, Liraglutide Biogaran
United Kingdom (Northern Ireland) · Diavic, Ligobesy
Croatia · Zegluxen
Hungary · Liendax
Ireland · Ejulir
Iceland · Ablymico, Liraglutide Stada
Italy · Byesilor, Diavic
Liechtenstein · Ablymico, Liraglutide Stada
Lithuania · Liraglutide Zentiva
Luxembourg · Zinnentis
Latvia · Liraglutide Zentiva, Siluxir
Norway · Ablymico, Liraglutid Zentiva
Poland · Byesilor, Diavic
Portugal · Liraglutido Farmoz, Liraglutido Pentafarma
Romania · Byesilor, Diavic
Sweden · Diavic, Ejulir
Slovakia · Sudaclin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e4cc8d63-5109-49c5-b859-a11719e79d36
GET /v1/drugs/e4cc8d63-5109-49c5-b859-a11719e79d36?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h133503_smpc.pdf",
  "strength": null,
  "atc_label": "Liraglutide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg133503",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "FENOL",
    "NATRIUMHYDROXIDE (E 524)",
    "PROPYLEENGLYCOL (E 1520)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "LIRAGLUTIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h133503.pdf",
  "authorised_at": "2025/11/11",
  "procedure_number": "SE/H/2572/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "133503",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about liraglutide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console